MERCK SHARP & DOHME LLC
CIK 64978 · last filed 2024-03-11
MERCK SHARP & DOHME LLC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing shows the insider bought $984.3M of HARP on Mar 11, 2024. Across all open-market trades the lifetime net is +$984.3M, making them a net buyer over the disclosed history. The firm reports its address in Rahway, NJ. 58 SEC filings were submitted jointly with Samuel O Md Thier.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HARP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
P.O. BOX 2000
RAHWAY, NJ 07065
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Harpoon Therapeutics, Inc. (HARP) Delisted | 10%+ Owner | 1,000 | $23.01 | $23.0K | $984.27M | 1 | 2024-03-11 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-11 | Harpoon Therapeutics, Inc. (HARP) Delisted | Buy (P) | +42,794,410 | $984.27M | EDGAR |
| 2007-10-09 | — | Other (J) | −3,206,318 | -$86.28M |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.